OBJECTIVE: To analyse the prognostic value of vascular endothelial growth factor (VEGF) in men with clinically localized prostate cancer. PATIENTS AND METHODS: Paraffin wax-embedded sections from the radical prostatectomy (RP) specimens of 40 men operated for clinically localized prostate cancer were used to build tissue microarrays. Of these patients, 17 had cancer progression and bone metastases after RP (group 1), and 23 remained free-of-tumour recurrence after RP (group 2). VEGF-A expression was examined in the RP specimens using immunohistochemistry. RESULTS: The groups had similar tumour characteristics in terms of prostate-specific antigen level, Gleason score, and pathological stage. VEGF-A expression was significantly higher in group 1 than in group 2 (P=0.046). In logistic regression analysis, VEGF-A expression was the most significant predictive factor of cancer progression after RP. CONCLUSION: VEGF-A expression in prostate cancer tissue is associated with the risk of cancer progression after RP. These results suggest that VEGF-A expression has a prognostic impact in clinically localized prostate cancer.
OBJECTIVE: To analyse the prognostic value of vascular endothelial growth factor (VEGF) in men with clinically localized prostate cancer. PATIENTS AND METHODS: Paraffin wax-embedded sections from the radical prostatectomy (RP) specimens of 40 men operated for clinically localized prostate cancer were used to build tissue microarrays. Of these patients, 17 had cancer progression and bone metastases after RP (group 1), and 23 remained free-of-tumour recurrence after RP (group 2). VEGF-A expression was examined in the RP specimens using immunohistochemistry. RESULTS: The groups had similar tumour characteristics in terms of prostate-specific antigen level, Gleason score, and pathological stage. VEGF-A expression was significantly higher in group 1 than in group 2 (P=0.046). In logistic regression analysis, VEGF-A expression was the most significant predictive factor of cancer progression after RP. CONCLUSION:VEGF-A expression in prostate cancer tissue is associated with the risk of cancer progression after RP. These results suggest that VEGF-A expression has a prognostic impact in clinically localized prostate cancer.
Authors: Brandon P Verdoorn; Changyong Feng; William A Ricke; Deepak M Sahasrabudhe; Deepak Kilari; Manish Kohli Journal: J Mens Health Date: 2012-09-01 Impact factor: 0.537
Authors: Silvan Boxler; Valentin Djonov; Thomas M Kessler; Ruslan Hlushchuk; Lucas M Bachmann; Ulrike Held; Regula Markwalder; George N Thalmann Journal: Am J Pathol Date: 2010-10-01 Impact factor: 4.307
Authors: Tiva T VanCleave; Jason H Moore; Marnita L Benford; Guy N Brock; Ted Kalbfleisch; Richard N Baumgartner; James W Lillard; Rick A Kittles; La Creis R Kidd Journal: Prostate Date: 2010-03-01 Impact factor: 4.104
Authors: Mina Cintho Ozahata; Grier P Page; Yuelong Guo; João Eduardo Ferreira; Carla Luana Dinardo; Anna Bárbara F Carneiro-Proietti; Paula Loureiro; Rosimere Afonso Mota; Daniela O W Rodrigues; André Rolim Belisario; Claudia Maximo; Miriam V Flor-Park; Brian Custer; Shannon Kelly; Ester Cerdeira Sabino Journal: J Sex Med Date: 2019-10-24 Impact factor: 3.802
Authors: Larry Pan; Seunghee Baek; Pamela R Edmonds; Mack Roach; Harvey Wolkov; Satish Shah; Alan Pollack; M Elizabeth Hammond; Adam P Dicker Journal: Radiat Oncol Date: 2013-04-25 Impact factor: 3.481
Authors: Jonah R Riddell; Patricia Maier; Stephanie N Sass; Michael T Moser; Barbara A Foster; Sandra O Gollnick Journal: PLoS One Date: 2012-11-21 Impact factor: 3.240